Document is current
Any future updates will be listed below
-
Authors
Pappas, Dimitrios A. http://orcid.org/0000-0001-8338-027X
O’Brien, Jacqueline
Guo, Lin
Shan, Ying
Baker, Joshua F.
Kricorian, Gregory
Stryker, Scott
Collier, David H.
- License Information
-
More Information
Article History
Received: 30 March 2023
Accepted: 19 July 2023
First Online: 9 September 2023
Declarations
:
: All participating investigators obtained full IRB approval for conducting non-interventional research involving human subjects. Sponsor approval and continuing review were obtained through a central IRB (New England Independent Review Board, NEIRB No. 120160610). For academic investigative sites without a waiver to use the central IRB, full board approval was obtained from the respective governing IRBs; documentation of approval was submitted to CorEvitas, LLC before initiating any study procedure. All participants provided written informed consent before participating.
: Not applicable.
: Dimitrios A. Pappas: Member of the Board of Directors of Corrona Research Foundation; received honoraria/consulting fees from Novartis, Sanofi, Genentech/Roche, and AbbVie; and has an equity interest and is an employee of CorEvitas LLC. Jacqueline O’Brien, Lin Guo, and Ying Shan are employees of CorEvitas LLC. Joshua F. Baker: Received consulting fees from Bristol Myers Squibb, CorEvitas, Cumberland Pharmaceuticals, Gilead, and Pfizer. Gregory Kricorian, Scott Stryker, and David Collier are employees and stockholders of Amgen Inc.
